As shown in Fig. 2, while baseline levels of S100A8/9, S100A12, or CRP did not significantly predict JIA-ACR50 or JIA-ACR70 responses at months 4 or 16, they were significant predictors of greater clinical responses. This evidence concerns the gene CRP and juvenile idiopathic arthritis.